Patient D: Microdosing Ibogaine for Parkinson’s

Patient D: Microdosing Ibogaine for Parkinson’s

Interviewed by Lakshmi Narayan and Eric SwensonAt the time of this interview in 2019, Patient D was a 76-year old individual who was diagnosed with Parkinson’s five years before and was able to manage and improve his symptoms by microdosing ibogaine. He passed away in...

Addiction and the Core Wound with Deanne Adamson

Addiction and the Core Wound with Deanne Adamson

How does IBOGA work in a single treatment when traditional rehab and therapies fail? The answer is simple. It gets to the root cause. In the opinion of addiction expert Dr. Gabor Maté, who has worked with hundreds of addicts in the course of his practice, addiction is...

18-MC: the Synthetic Derivative of Ibogaine

18-MC: the Synthetic Derivative of Ibogaine

Stanley Glick, PhD, MD, shares his views on the past, present, and future of ibogaine and 18-MC and on the prejudice against addicts and psychedelic drugs that inhibits funding for medical research. Would you please give us a synopsis of the history of your research,...

×